Embecta Stock (NASDAQ: EMBC) stock price, news, charts, stock research, profile.
Open | $10.650 |
Close | $10.400 |
Volume / Avg. | 488.927K / 429.963K |
Day Range | 10.330 - 10.770 |
52 Wk Range | 9.925 - 32.000 |
Market Cap | $598.821M |
P/E Ratio | 11.344 |
Dividend Yield | 5.510% |
Exchange | NASDAQ |
RSI | 31 |
Short Interest | 7.48% |
Days to Cover | 8.01 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Embecta (NASDAQ: EMBC) through any online brokerage.
Other companies in Embecta’s space includes: Solventum (NYSE:SOLV), RxSight (NASDAQ:RXST), TELA Bio (NASDAQ:TELA), Align Tech (NASDAQ:ALGN) and ICU Medical (NASDAQ:ICUI).
The latest price target for Embecta (NASDAQ: EMBC) was reported by Morgan Stanley on Wednesday, November 22, 2023. The analyst firm set a price target for 16.00 expecting EMBC to rise to within 12 months (a possible 53.85% upside). 5 analyst firms have reported ratings in the last year.
The stock price for Embecta (NASDAQ: EMBC) is $10.4 last updated Today at April 25, 2024 at 4:20 PM EDT.
A quarterly cash dividend of $0.15 per share of Class A Common Stock. The quarterly cash dividend was payable on March 15, 2024 to stockholders of record on February 27, 2024.
Embecta’s Q2 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for Embecta.
Embecta is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.